Vandetanib Give Medullary Thyroid Cancer Patients A Second Chance

mdanderson has 391 videos Subscribe Here

Description: In April, the U.S. Food and Drug Administration approved the use of vandetanib for the treatment of medullary thyroid carcinoma.

MD Anderson's Dr. Robert Gagel who with his team helped to bring about the FDA's approval of vandetanib talks about the drug, the research and it's benefit to medullary thyroid cancer patients.
Shared By : mdanderson
Posted on : 06/03/11
Added : 8 years ago
Category : General